Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART‐1) trial design

AIMS: Cardiopoiesis is a conditioning programme that aims to upgrade the cardioregenerative aptitude of patient‐derived stem cells through lineage specification. Cardiopoietic stem cells tested initially for feasibility and safety exhibited signs of clinical benefit in patients with ischaemic heart...

Descripción completa

Detalles Bibliográficos
Autores principales: Bartunek, Jozef, Davison, Beth, Sherman, Warren, Povsic, Thomas, Henry, Timothy D., Gersh, Bernard, Metra, Marco, Filippatos, Gerasimos, Hajjar, Roger, Behfar, Atta, Homsy, Christian, Cotter, Gad, Wijns, William, Tendera, Michal, Terzic, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Focus Issue on Cardiac Regeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064644/
https://www.ncbi.nlm.nih.gov/pubmed/26662998
http://dx.doi.org/10.1002/ejhf.434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5064644/
https://www.ncbi.nlm.nih.gov/pubmed/26662998
http://dx.doi.org/10.1002/ejhf.434

Ejemplares similares